Literature DB >> 18466775

Detection of mitochondrial dysfunction by EPR technique in mouse model of dilated cardiomyopathy.

Martyna Elas1, Joanna Bielanska, Katarzyna Pustelny, Przemyslaw M Plonka, Lukasz Drelicharz, Tomasz Skorka, Urszula Tyrankiewicz, Miroslaw Wozniak, Sylwia Heinze-Paluchowska, Michal Walski, Leszek Wojnar, Dominique Fortin, Renee Ventura-Clapier, Stefan Chlopicki.   

Abstract

Tgalphaq44 mice with targeted overexpression of activated Galphaq protein in cardiomyocytes mimic many of the phenotypic characteristics of dilated cardiomyopathy in humans. However, it is not known whether the phenotype of Tgalphaq44 mice would also involve dysfunction of cardiac mitochondria. The aim of the present work was to examine changes in EPR signals of semiquinones and iron in Fe-S clusters, as compared to classical biochemical indices of mitochondrial function in hearts from Tgalphaq44 mice in relation to the progression of heart failure. Tgalphaq44 mice at the age of 14 months displayed pulmonary congestion, increased heart/body ratio and impairment of cardiac function as measured in vivo by MRI. However, in hearts from Tgalphaq44 mice already at the age of 10 months EPR signals of semiquinones, as well as cyt c oxidase activity were decreased, suggesting alterations in mitochondrial electron flow. Furthermore, in 14-months old Tgalphaq44 mice loss of iron in Fe-S clusters, impaired citrate synthase activity, and altered mitochondrial ultrastructure were observed, supporting mitochondrial dysfunction in Tgalphaq44 mice. In conclusion, the assessment of semiquinones content and Fe(III) analysis by EPR represents a rational approach to detect dysfunction of cardiac mitochondria. Decreased contents of semiquinones detected by EPR and a parallel decrease in cyt c oxidase activity occurs before hemodynamic decompensation of heart failure in Tgalphaq44 mice suggesting that alterations in function of cardiac mitochondria contribute to the development of the overt heart failure in this model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18466775     DOI: 10.1016/j.freeradbiomed.2008.04.016

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  13 in total

1.  Protein kinase D activation induces mitochondrial fragmentation and dysfunction in cardiomyocytes.

Authors:  Bong Sook Jhun; Jin O-Uchi; Stephanie M Adaniya; Thomas J Mancini; Jessica L Cao; Michelle E King; Amy K Landi; Hanley Ma; Milla Shin; Donqin Yang; Xiaole Xu; Yisang Yoon; Gaurav Choudhary; Richard T Clements; Ulrike Mende; Shey-Shing Sheu
Journal:  J Physiol       Date:  2018-01-25       Impact factor: 5.182

2.  Mössbauer Spectra of Mouse Hearts Reveal Age-dependent Changes in Mitochondrial and Ferritin Iron Levels.

Authors:  Joshua D Wofford; Mrinmoy Chakrabarti; Paul A Lindahl
Journal:  J Biol Chem       Date:  2017-02-15       Impact factor: 5.157

Review 3.  Mitochondria as a therapeutic target in heart failure.

Authors:  Marina Bayeva; Mihai Gheorghiade; Hossein Ardehali
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

4.  Heme levels are increased in human failing hearts.

Authors:  Arineh Khechaduri; Marina Bayeva; Hsiang-Chun Chang; Hossein Ardehali
Journal:  J Am Coll Cardiol       Date:  2013-03-06       Impact factor: 24.094

Review 5.  Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications.

Authors:  Jin-Qiang Chen; Patrick R Cammarata; Christopher P Baines; James D Yager
Journal:  Biochim Biophys Acta       Date:  2009-06-23

6.  Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.

Authors:  Andrzej Fedorowicz; Łukasz Mateuszuk; Grzegorz Kopec; Tomasz Skórka; Barbara Kutryb-Zając; Agnieszka Zakrzewska; Maria Walczak; Andrzej Jakubowski; Magdalena Łomnicka; Ewa Słomińska; Stefan Chlopicki
Journal:  Respir Res       Date:  2016-08-31

7.  Increased Heme Levels in the Heart Lead to Exacerbated Ischemic Injury.

Authors:  Konrad Teodor Sawicki; Meng Shang; Rongxue Wu; Hsiang-Chun Chang; Arineh Khechaduri; Tatsuya Sato; Christine Kamide; Ting Liu; Sathyamangla V Naga Prasad; Hossein Ardehali
Journal:  J Am Heart Assoc       Date:  2015-07-31       Impact factor: 5.501

8.  Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation.

Authors:  Thomas L Lynch; Mayandi Sivaguru; Murugesan Velayutham; Arturo J Cardounel; Michelle Michels; David Barefield; Suresh Govindan; Cristobal dos Remedios; Jolanda van der Velden; Sakthivel Sadayappan
Journal:  Oxid Med Cell Longev       Date:  2015-10-05       Impact factor: 6.543

9.  Immuno-Spin Trapping-Based Detection of Oxidative Modifications in Cardiomyocytes and Coronary Endothelium in the Progression of Heart Failure in Tgαq*44 Mice.

Authors:  Bartosz Proniewski; Joanna Czarny; Tamara I Khomich; Kamil Kus; Agnieszka Zakrzewska; Stefan Chlopicki
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

10.  Vascular Cognitive Impairment Linked to Brain Endothelium Inflammation in Early Stages of Heart Failure in Mice.

Authors:  Mateusz G Adamski; Magdalena Sternak; Tasnim Mohaissen; Dawid Kaczor; Joanna M Wierońska; Monika Malinowska; Iwona Czaban; Katarzyna Byk; Kristina S Lyngsø; Kamil Przyborowski; Pernille B L Hansen; Grzegorz Wilczyński; Stefan Chlopicki
Journal:  J Am Heart Assoc       Date:  2018-03-26       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.